April 30, 2025 (MLN): Highnoon Laboratories Limited (PSX: HINOON) reported a profit after tax of Rs954.56 million for the first quarter ended 31 March 2025, reflecting an 18% increase compared to Rs809.02m in SPLY.
The pharmaceutical company’s revenue rose 14% year-on-year to Rs7.03 billion from Rs6.14bn, driven by stronger customer contracts.
Gross profit surged 22% to Rs3.68bn, while the cost of sales climbed 7% to Rs3.34bn.
Operating profit increased 26% to Rs1.34bn, despite higher expenses across key segments.
Distribution, selling, and promotional expenses jumped 20% to Rs1.87bn, while administrative and general expenses rose 24% to Rs330.44m.
Research and development spending more than tripled to Rs17.16m.
Other income grew by 36% to Rs97.83m, offsetting a 40% spike in finance costs to Rs27.76m.
The company also incurred a levy of Rs4.84m during the quarter. Taxation rose sharply by 46% to Rs451.79m.
Earnings per share (EPS) for the period stood at Rs18.02, up from Rs15.27 in Q1 2024.
| Condensed interim consolidated statement of profit and loss for the first quarter ended 31 March 2025 (in Rupees) | 2025 | 2024 | %Change |
| Revenue from contracts with customers – net | 7,025,898,202 | 6,141,870,352 | 14% |
| Cost of sales | (3,342,282,703) | (3,118,635,482) | 7% |
| Gross profit | 3,683,615,499 | 3,023,234,870 | 22% |
| Distribution, selling and promotional expenses | (1,874,627,715) | (1,556,935,464) | 20% |
| Administrative and general expenses | (330,442,883) | (265,676,308) | 24% |
| Research and development expenses | (17,160,193) | (5,660,704) | 203% |
| Other operating expenses | (120,269,365) | (127,575,036) | -6% |
| Operating profit | 1,341,115,343 | 1,067,387,358 | 26% |
| Other income | 97,833,917 | 71,917,975 | 36% |
| Finance costs | (27,757,244) | (19,859,822) | 40% |
| Profit before income tax and levy | 1,411,192,016 | 1,119,445,511 | 26% |
| Levy | (4,838,674) | – | |
| Profit before income tax | 1,406,353,342 | 1,119,445,511 | 26% |
| Taxation | (451,789,185) | (310,421,298) | 46% |
| Profit after tax for the period | 954,564,157 | 809,024,213 | 18% |
| Earnings per share – basic and diluted | 18.02 | 15.27 |
Copyright Mettis Link News
Posted on: 2025-04-30T15:18:30+05:00
